Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
BMC Pulmonary Medicine|June 10, 2014
Flagellin concentrations in expectorations from cystic fibrosis patientsViviane Balloy, Guiti Thévenot, Thierry Bienvenu, et al.
Plos One|July 7, 2012
A crucial role of Flagellin in the induction of airway mucus production by Pseudomonas aeruginosaFatima Ben Mohamed, Fatima Ben Mohamed, Ignacio Garcia-Verdugo, et al.
Jac-Antimicrobial Resistance|March 20, 2023
Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)Alexander C Branton, Catherine H Vu, Veena Venugopalan, et al.
Diagnostic Microbiology and Infectious Disease|January 5, 2005
Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United StatesSujata M Bhavnani, Jeffrey P Hammel, Ronald N Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2010
Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditisSujata M Bhavnani, Christopher M Rubino, Paul G Ambrose, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study TeamRonald N Jones, Christopher M Rubino, Sujata M Bhavnani, et al.
The Journal of Antimicrobial Chemotherapy|February 28, 2002
Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepimePaul G Ambrose, Robert C Owens, Michael J Garvey, et al.
Diagnostic Microbiology and Infectious Disease|July 16, 2008
Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strainsRonald N Jones, Douglas J Biedenbach, Paul G Ambrose, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2018
We can do better: a fresh look at echinocandin dosingJustin C Bader, Sujata M Bhavnani, David R Andes, et al.
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patientsScott A Van Wart, David R Andes, Paul G Ambrose, et al.
Pageof 17